Endo International PLC (0Y5F)
London Exchange · UK · prices in USD · close of 15 Oct 2026
Key indicators
| Last close | USD 1,075.62 |
|---|---|
| 52-week range | 833.13 – 1,151.58 |
| Return, 1 month / 3 months | −4.8% / +2.1% |
| Return, 1 year / 3 years | +28.6% / +107.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 13.9% |
| Worst drawdown (1 year) | -9.1% |
| Average daily value traded | 0.00M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Endo International is a specialty pharmaceutical company that develops, makes and sells generic and branded medicines. Its products include pain treatments, urology and other specialty drugs, and sterile injectable medicines supplied to hospitals and clinics. The company serves patients, physicians and healthcare providers, mainly in the United States, and is incorporated in Ireland with its operational base in Pennsylvania.
On this site Endo International PLC appears as a stock on the London Exchange (UK), code 0Y5F, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Endo International PLC (0Y5F) trades on the London Exchange in UK. It last closed at USD 1,075.62 on 15 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,165 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 28.6% and over the last three months it rose 2.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.7% | ||
| From 52-week high | -6.6% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.1% | ||
| 6-month return | -0.8% | ||
| 12-month return, skipping the last month | 35.1% | ||
| Stability (higher is calmer) | 95 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 13.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -9.1% | ||
| Liquidity | 1 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M USD | ||
| Zero-volume days | 100.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.7% |
|---|---|
| 1 month | −4.8% |
| 3 months | +2.1% |
| 6 months | −0.8% |
| 1 year | +28.6% |
| 3 years | +107.2% |
| 5 years | +45.8% |
Signals
| 50-day / 200-day average | 1,108.62 / 1,057.93 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 6.42 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.